Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ephraim J Fuchs

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Seminars in Hematology|October 30, 2016
Selecting the best haploidentical donorShannon R McCurdy, Ephraim J Fuchs
Advances in Hematology|December 30, 2015
Comparable Outcomes for Hematologic Malignancies after HLA-Haploidentical Transplantation with Posttransplantation Cyclophosphamide and HLA-Matched TransplantationShannon R McCurdy, Ephraim J Fuchs
Current Opinion in Hematology|August 7, 2016
Allogeneic stem cell transplantation for sickle cell diseaseTara M Robinson, Ephraim J Fuchs
Current Opinion in Oncology|February 26, 2003
Nonmyeloablative alternative donor transplantsLeo Luznik, Paul V O'Donnell, Ephraim J Fuchs
Seminars in Oncology|December 5, 2012
Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantationLeo Luznik, Paul V O'Donnell, Ephraim J Fuchs
Nature Reviews. Clinical Oncology|August 26, 2015
Modern approaches to HLA-haploidentical blood or marrow transplantationChristopher G Kanakry, Ephraim J Fuchs, Leo Luznik
Current Opinion in Hematology|September 10, 2010
High-dose cyclophosphamide for graft-versus-host disease preventionLeo Luznik, Richard J Jones, Ephraim J Fuchs
Nature Reviews. Clinical Oncology|January 1, 2016
Modern approaches to HLA-haploidentical blood or marrow transplantationChristopher G Kanakry, Ephraim J Fuchs, Leo Luznik
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2009
HLA-haploidentical stem cell transplantation for hematologic malignanciesEphraim J Fuchs, Xiao-jun Huang, Jeffrey S Miller
Best Practice & Research. Clinical Haematology|September 20, 2011
Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamideAshley T Munchel, Yvette L Kasamon, Ephraim J Fuchs
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Seminars in Hematology|October 30, 2016
Selecting the best haploidentical donorShannon R McCurdy, Ephraim J Fuchs
Advances in Hematology|December 30, 2015
Comparable Outcomes for Hematologic Malignancies after HLA-Haploidentical Transplantation with Posttransplantation Cyclophosphamide and HLA-Matched TransplantationShannon R McCurdy, Ephraim J Fuchs
Current Opinion in Hematology|August 7, 2016
Allogeneic stem cell transplantation for sickle cell diseaseTara M Robinson, Ephraim J Fuchs
Current Opinion in Oncology|February 26, 2003
Nonmyeloablative alternative donor transplantsLeo Luznik, Paul V O'Donnell, Ephraim J Fuchs
Seminars in Oncology|December 5, 2012
Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantationLeo Luznik, Paul V O'Donnell, Ephraim J Fuchs
Nature Reviews. Clinical Oncology|August 26, 2015
Modern approaches to HLA-haploidentical blood or marrow transplantationChristopher G Kanakry, Ephraim J Fuchs, Leo Luznik
Current Opinion in Hematology|September 10, 2010
High-dose cyclophosphamide for graft-versus-host disease preventionLeo Luznik, Richard J Jones, Ephraim J Fuchs
Nature Reviews. Clinical Oncology|January 1, 2016
Modern approaches to HLA-haploidentical blood or marrow transplantationChristopher G Kanakry, Ephraim J Fuchs, Leo Luznik
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2009
HLA-haploidentical stem cell transplantation for hematologic malignanciesEphraim J Fuchs, Xiao-jun Huang, Jeffrey S Miller
Best Practice & Research. Clinical Haematology|September 20, 2011
Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamideAshley T Munchel, Yvette L Kasamon, Ephraim J Fuchs
Pageof 12